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Hydrogen peroxide mediates FK506-induced cytotoxicity in re-
nal cells.
Background. The nephrotoxicity induced by immunosup-
pressant FK506 remains a serious clinical problem, and the un-
derlying mechanism has not been completely understood. The
present study was undertaken to determine the role of hydro-
gen peroxide in FK506-mediated cytotoxicity in a porcine renal
proximal tubular cell line, LLC-PK1 cells, and human embry-
onic kidney (HEK293) cells.
Methods. Cytotoxicity was estimated by crystal violet and
lactate dehydrogenase release assays. The activity of reactive
oxygen species (ROS) was detected by flow cytometry. FK506-
induced cell death was examined in the presence of the hydro-
gen peroxide scavenger, catalase, or a scavenger of hydroxyl
radicals, sodium benzoate. As a control, FK506-induced cell
death was also measured in the presence of superoxide anion
inhibitor, 4,5-dihydroxy-1,2-benzene disulfonic acid (Tiron),
TEMPO, or overexpressed human manganese superoxide dis-
mutase (MnSOD). Catalase was also used in tumor necro-
sis factor-a (TNF-a)-induced cell injury to determine whether
the enzyme specifically protected cells against FK506-mediated
cytotoxicity.
Results. FK506 induced cell death in a dose-dependent man-
ner and coincided with a dose-dependent increase in ROS ac-
tivity. Abrogation of FK506-mediated ROS by catalase and
N-acetylcysteine blunted FK506-induced cell death. Further-
more, overexpression of catalase, sodium benzoate, and defer-
oxamine inhibited the cytotoxic effect of FK506. In contrast,
Tiron, TEMPO, or overexpression of human MnSOD failed to
show cytoprotection. In fact, TEMPO or expression of MnSOD
enhanced the effect of FK506. Catalase did not significantly
affect TNF-a–induced cell injury.
Conclusion. Catalase is uniquely required in cellular protec-
tion against FK506 cytotoxicity, which suggests an important
role for hydrogen peroxide in the cellular actions of FK506.
Key words: FK506, cell death, LLC-PK1 cells, HEK293 cells, reactive
oxygen species, hydrogen peroxide, catalase, and MnSOD.
Received for publication June 10, 2003
and in revised form August 11, 2003
Accepted for publication August 19, 2003
C© 2004 by the International Society of Nephrology
Introduction of immunosupressants such as cy-
closporine A (CsA) and FK506 has dramatically im-
proved the short-term graft survival rate of solid organ
transplantation. FK506 is 10 to 100 times more potent
than CsA in the suppression of T-cell activation and is
often used when CsA is not effective in acute rejection or
due to intolerance [1, 2]. However, the nephrotoxicity in-
duced by FK506 remains a serious problem. FK506 causes
hyalinosis of afferent arterioles, progressive striped in-
terstitial fibrosis, and loss of cellularity in the area of fi-
brosis [3, 4]. Most tubular injuries occur in the proximal
tubules [3–6]. One of the possible reasons is that the renal
proximal tubules have a high dependence on oxidative
phosphorylation for energy production, and thus may be
susceptible to oxidative stress [7]. Antioxidants inhibit
CsA-induced cytotoxicity both in vitro and in vivo [8,
9]. As compared with CsA, the role of reactive oxygen
species (ROS) in FK506-induced cell death has attracted
much less attention.
ROS are mainly composed of superoxide and hydroxyl
anions and hydrogen peroxide. The targets of oxidants
include membrane lipids and proteins, DNA, enzymes of
the glycolytic pathway, mitochondria, and cytoskeletal
elements. Superoxide anion can directly react with these
targets. The deleterious effects of hydrogen peroxide are
primarily mediated by hydroxyl radicals that are formed
through Haber-Weiss-Fenton reaction and are more
toxic than superoxide anion. However, cells have well-
developed antioxidant systems, including superoxide dis-
mutase, that catalyze the conversion of superoxide anion
to hydrogen peroxide, catalase, and glutathione perox-
idase that convert hydrogen peroxide to oxygen and
water. The detrimental effect of ROS only happens when
the steady state of detoxification reactions is interrupted
either due to overproduction of ROS or compromised
antioxidant systems [7]. Tada et al [10] have recently
demonstrated that FK506 depresses renal catalase activ-
ity. This raises an intriguing question regarding whether
overexpression of catalase blunts FK506-induced
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nephrotoxicity. In the present study, we first investigated
the role of ROS in FK506-induced cell death in LLC-
PK1 cells, a porcine renal proximal tubular cell line. We
then studied the effect of overexpression of the human
catalase on FK506-induced cell death in LLC-PK1 cells
and human embryonic kidney 293 (HEK293) cells. We
have found that overexpression of catalase ameliorates
FK506-mediated cytotoxicity, which suggests a critical
role of hydrogen peroxide in this type of cell injury.
METHODS
Materials
FK506 (Fujisawa, Deerfield, IL, USA, and Cal-
Biochem, San Diego, CA, USA) was dissolved in
dimethyl sulfoxide (DMSO). All other chemicals
were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). TEMPO was dissolved in DMSO. N-
acetylcysteine (200 mmol/L) was dissolved in M-199
medium directly, and the solution was adjusted to pH 7.4
with 10 N NaOH. Sodium benzoate (1 mol/L) was also
dissolved in M-199 medium directly.
Cell culture and treatment
LLC-PK1 and HEK293 cells were purchased from
American Tissue Culture Collection (ATCC) (Manassas,
VA, USA) and kept in Medium-199 plus 3% fetal bovine
serum (FBS) and Dulbecco’s modified Eagle’s medium
(DMEM) plus 10% FBS, respectively, in a 37◦C incubator
supplied with 95% room air and 5% CO2. For assays of
cell viability, cells were plated at a density of 6 × 104 cells
per well in a 96-well plate and grown for 16 to 20 hours un-
til they reached confluency before treatments. Cells were
preincubated with an antioxidant for 30 minutes except
for sodium benzoate and deferoxamine that were prein-
cubated for 60 minutes prior to addition of FK506. DMSO
was included in the control if a drug that was dissolved in
DMSO was used in the treated group.
Crystal violet assay
Cells were stained with 0.5% crystal violet in methanol
for 8 to 10 minutes at 22◦C and then washed three times
with 1× phosphate-buffered saline (PBS) solution. The
absorption measured at 550 nm with a 96-well plate
reader was used as an index for cell viability [11].
Lactate dehydrogenase (LDH) assay
LDH assays were performed according to the manu-
facturer’s instruction (Sigma Chemical Co.). The mean of
the rates of decrease in absorption at 340 nm in controls
was arbitrarily set as 100%. The rates from rest of experi-
ments were normalized with this value. Each experiment
was performed in duplicate or triplicate.
Cytofluorometric analyses of propidium iodide staining
Briefly, after treatments, both detached and attached
cells were collected and incubated in a hypotonic fluo-
rochrome solution (propidium iodide, 0.5 mg/mL, in 0.1%
sodium citrate plus 0.1% Triton X-100) overnight at 4◦C.
The propidium iodide fluorescence of each individual nu-
cleus was measured with excitation of 488 nm and emis-
sion of 620 nm. The cell debris was excluded from analysis
by appropriately raising the forward scatter threshold.
Hypodiploid nuclei due to the condensation of nuclear
chromatin appeared at sub G0/G1 position [12].
Caspase-3 like activity assay
The activity of caspase-3-like proteases was measured
as increases in hydrolysis of fluorogenic tetrapeptide
substrate, Ac-DEVD-7-amino-4-methylcoumarin (Ac-
DEVD-AMC), according to the manufacturer’s instruc-
tions (Biomol, Plymouth Meeting, PA, USA). Because
caspase-7 also cleaves the substrate, the activity obtained
here is referred as caspase-3–like activity. Briefly, the
cells were lysed in 25 mmol/L HEPES buffer (pH
7.5) containing 5 mmol/L ethylenediaminetetraacetic
acid (EDTA), 2 mmol/L dithiothreitol (DTT), 0.1%
CHAPS (3-[(-cholamidopropyl)dimethylammonio]-
1-propanesulfonate), and 0.1% Triton X-100 at 22◦C
for 10 minutes, then the supernatants were taken for
measurement of hydrolysis of Ac-DEVD-AMC as a
function of time at 22◦C.
ROS measurement
Cells were trypsinized and used as a suspension. Cells
were preloaded with 20 lmol/L freshly prepared 2′ 7′-
dichlorofluorescin diacetate (DCF-DA), in ethanol, in
phenol-red DMEM at 37◦C for 20 minutes, and then
treated. The cells were analyzed by flow cytometry with
excitation at 475 nm and emission at 525 nm, using soft-
ware System II (Coulter Corporation, Miami, FL, USA)
[9]. The gate was appropriately set to distinguish oxidant-
stressed cells from nonoxidant-stressed cells. The mean
of readings in controls was arbitrated as 100%. The rest
of data was normalized to this value. Each experiment
was performed in duplicate or triplicate [12].
Stable transfection
A human catalase cDNA (pcDNA3.1/catalase) was
transfected into LLC-PK1 cells with lipofectAMINE ac-
cording to the manufacturer’s recommendation (Life
Technologies, Gaithersburg, MD, USA)[13]. Stable
clones were selected with and kept under 200 lg/mL
zeocin. The positive clones expressing catalase were iden-
tified by immunoblot analysis. A dominant negative mu-
tant cDNA of the human IjBa (gift of Dr. Dean Ballard,
Vanderbilt University) [14] in which the serine residue
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Fig. 1. FK506 induces dose-dependent
cell death that is associated with increased
presence of hypodiploid nuclei and caspase-3
like activity in LLC-PK1 cells. Cell viability
was estimated by crystal violet (A) or lactate
dehydrogenase (LDH) release (B) assays
24 hours after treatment. Caspase-3 like activ-
ity (C) was measured 4 hours after treatments
by hydrolysis Ac-DEVD-7-amino-4-
methylcoumarin (Ac-DEVD-AMC) as a
function of time with fluorometry. Each
experiment was performed in duplicate or
triplicate. aP < 0.01; bP < 0.05 as compared
with respective control [dimethyl sulfoxide
(DMSO only)] [N = 4, analyses of variance
(ANOVA)]. Hypodiploid nuclei (sub G0/G1
fraction) were detected with propidium
iodide–based flow cytometry 24 hours after
treatment, and the scale is same for each fig-
ure. (D) DMSO only. (E) FK506, 40 lmol/L.
(F) FK506 60 lmol/L. A representative of
two independent experiments.
Ce
ll n
um
be
r
Su
b 
G
0/G
1 
0.
1%
DNA content
D
Ce
ll n
um
be
r
Su
b 
G
0/G
1 
12
%
DNA content
E
Ce
ll n
um
be
r
Sub G0/G1 67%
DNA content
F
at 32 position was mutated to alanine was transfected
in LLC-PK1 cells with lipofectin according to the man-
ufacturer’s protocol (Life Technologies). Stable clones
were selected with and kept under 600 lg/mL G418.
The positive clones expressing the mutant cDNA were
screened with electrophoretic mobility shift assays, which
were performed according to previously described meth-
ods [14] and confirmed by the sensitivity to tumor
necrosis factor-a (TNF-a)-induced cytotoxicity. Stable
clones of HEK293 cells overexpressing human man-
ganese superoxide dismutase (MnSOD) and catalase,
described previously [13], were also used in separate
experiments.
Immunoblot analysis (Western analysis)
LLC-PK1 cells were rinsed with ice-cold PBS, scraped
with a rubber policeman in a loading buffer supple-
mented with 5% b-mercaptoethanol and 0.1 mg/mL
phenylmethysulfonyl fluoride (PMSF) and 0.04 lg/mL
aprotinin. Samples were loaded into 10% sodium do-
decyl sulfate (SDS)-polyacrylamide gel (12 lg/lane), re-
solved by electrophoresis, and electrophoretically blotted
onto polyvinylidine difluoride (PVDF) membranes. The
membranes were first hybridized with an antibody recog-
nizing the human catalase (Calbiochem) and then with
horseradish-peroxidase-conjugated antirabbit IgG sec-
ondary antibody (Sigma Chemical Co.). Antibody bind-
ings were visualized by enhanced chemiluminescence
method (Amersham, Buckinghamshire, UK).
Electrophoretic mobility shift assay
Briefly, nuclear extracts were prepared according to
methods previously described [14]. Protein-DNA com-
plexes were formed at 22◦C for 20 minutes in a 20 lL re-
action containing 25 mmol/L HEPES, pH 7.9, 50 mmol/
L KCl, 5 mmol/L MgCl2, 1.5 mmol/L DTT, 0.1 mmol/
L EDTA, l0% glycerol, 3 lg dI-dC, 0.05 ng 32P-
labeled oligonucleotide (approximately 20000 cpm),
and 5 lg of nuclear extracts. The nuclear factor-
kappaB (NF-jB) consensus oligonucleotide (Promega
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Fig. 2. FK506 increases reactive oxygen
species (ROS) activity in a dose-dependent
manner, and abrogation of ROS activity
by catalase and N-acetylcysteine (NAC) in-
hibits FK506-induced cell death in LLC-PK1
cells. (A) The ROS activity was detected by
2′ 7′-dichlorofluorescin diacetate (DCF-DA)-
based flow cytometry 40 minutes after incu-
bation with FK506 (). Cells were incubated
with catalase () or N-acetylcysteine (NAC)
() for 30 minutes prior to addition of FK506.
(B and C) Cells were treated with 60 lmol/L
FK506. Standard error bars of ROS activ-
ity measured with antioxidants are too small
to be seen. Cell viability was determined by
crystal violet assays 24 hours after treatments.
Each experiment was performed in duplicate
or triplicate. aP < 0.01 as compared with re-
spective control [N = 4, analyses of variance
(ANOVA)].
Corp., Madison, WI, USA) had the following sequence:
5′-AGTTGAGGGGACTTTCCCAGGC-3′. Complexes
were resolved in 5% nondenaturing polyacrylamide gels
containing 0.5 × Tris-borate-EDTA (TBE) buffer and
detected by autoradiography. For competition assays a
25-fold excess of unlabeled NF-jB consensus oligonu-
cleotide was included in binding reactions.
Statistical analysis
All numerical data are expressed as means ± standard
errors. Statistical analyses were performed by Student
t test or analyses of variance (ANOVA) as appropriate.
Multiple post hoc comparisons were made by Dunnett
analyses. P value less than 0.05 was considered significant.
RESULTS
FK506 induces cell death
FK506 caused a significant decrease in survival of LLC-
PK1 cells in a dose-dependent manner based on crystal
violet assays. After incubation with 60 lmol/L FK506
for 24 hours, only 18.2 ± 0.2% of the cells survived
(Fig. 1A). FK506 had a narrow window of toxicity. FK506
at 40 lmol/L was not toxic. The increase of the dose by
50% almost completely killed the cells. Analyses with
medium LDH activity demonstrated that FK506-induced
cell death was associated with a dose-dependent release
of LDH (Fig. 1B). Cell death was also accompanied with
an increase in caspase-3 like activity, the biochemical ev-
idence of apoptosis (Fig. 1C). Flow cytometric analyses
revealed that FK506 increased presence of hypodiploid
nuclei, the morphologic evidence of apoptosis (Fig. 1D to
F). The amount of hypodiploid nuclei under control con-
dition was negligible. Treatment of cells with 60 lmol/L
FK506 increased the amount of hypodiploid nuclei by ap-
proximately sixfold as compared with the group treated
with 40 lmol/L FK506.
FK506-induced cytotoxicity is entirely
dependent on ROS
FK506 increased activity of ROS, measured by the
DCF-DA–based flow cytometry, in a dose-dependent
manner. Catalase (500 U/mL) and N-acetylcysteine
(15 mmol/L), a membrane-permeable precursor of
reduced glutathione that is important for the activity of
glutathione peroxidase, abrogated the effect of FK506
on ROS activity (Fig. 2A). Catalase and N-acetylcysteine
reduced ROS activity below 100% that was arbitrated
for the control. This is possibly due to the inhibitory
effects of antioxidants on the basal production of ROS.
To determine whether ROS were responsible for FK506-
induced killing, crystal violet assays were repeated in
the presence of catalase and N-acetylcysteine. Both
antioxidants abrogated FK506-induced cell death in a
dose-dependent manner (Fig. 2B and C).
Hydrogen peroxide, but not superoxide anion,
mediates FK506-induced cytotoxicity
Since FK506 increased catalase-inhibitable ROS ac-
tivity and catalase inhibited FK506-induced cell injury,
we sought to examine the role of hydrogen peroxide in
FK506-induced cell death. We first overexpressed cata-
lase in LLC-PK1 cells and examined the cytotoxicity of
hydrogen peroxide. We found that exposure of LLC-
PK1 cells to hydrogen peroxide caused dose-dependent
cell death that was abolished by overexpression of cata-
lase as expected (Fig. 3A and B). We then treated
cells with FK506 and found that overexpression of cata-
lase also inhibited FK506-induced cell death (Fig. 3C).
Since the effect of hydrogen peroxide is mediated by
hydroxyl radicals that are produced in the presence of
iron, we examined the effect of FK506 in the presence
of sodium benzoate (50 mmol/L), a scavenger of hy-
droxyl radicals, or deferoxamine (400 lmol/L), a chelator
of iron. Like catalase, sodium benzoate or deferoxam-
ine inhibited FK506-induced cell death (Fig. 3D or E).
Zhou et al: Hydrogen peroxide mediates FK506 cytotoxicity 143
Catalase
W
id
e-
ty
pe
Ca
ta
la
se
Em
pt
y
ve
ct
or
A
0
120
100
Ce
ll v
ia
bi
lity
,
 
% 80
60
40
20
0
200 400
Hydrogen peroxide, µmol/L
600 800
B
D
120
100
Ce
ll v
ia
bi
lity
,
 
% 80
60
40
20
0
FK506, 60 µmol/L
Sodium benzoate,
50 mmol/L
– – + +
– + – +
a
120
C
100
Ce
ll v
ia
bi
lity
,
 
% 80
60
40
20
0
0 20
FK506, 60 µmol/L
40 60 80
aa
a
a
a
a
Fig. 3. Overexpression of human catalase in-
hibits hydrogen peroxide- or FK506-induced
cell death in LLC-PK1 cells. (A) Overex-
pression of human catalase was identified by
immunoblot analysis as a band at 52 kD.
(B) Overexpression of human catalase abol-
ished hydrogen peroxide-induced cell death.
Symbols are: () wild-type cells; (•) Cells
transfected with empty vector. () Cells ex-
pressing the human catalase. (C) Overex-
pression of the human catalase inhibited
FK506-mediated cell injury. Symbols are:
() Cells transfected with empty vector; ()
Cells expressing human catalase. (D) Sodium
benzoate blunted FK506-mediated cytotox-
icity. (E) Deferoxamine attenuated FK506-
induced cell injury. Cells were incubated with
sodium benzoate or deferoxamine for 60 min-
utes prior to addition of FK506. Cell viability
was determined by the crystal violet assay 24
hours after treatments. Each experiment was
performed in duplicate or triplicate. aP < 0.01
as compared with respective control [N = 4,
analyses of variance (ANOVA) or Student t
test].
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To determine the role of superoxide anion, we examined
the effect of FK506 in the presence of 4,5-dihydroxy-
1,2-benzene disulfonic acid (Tiron) (3 mmol/L), a scav-
enger of superoxide anion, and TEMPO (1 mmol/L),
a membrane-permeable mimetic of superoxide dis-
mutase. Neither Tiron nor TEMPO inhibited FK506-
induced cell death (Fig. 4). In fact, TEMPO enhanced
FK506-induced cell death, being associated with in-
creased ROS activity (Fig. 4). These data suggest that
superoxide anion is not critical in FK506-induced cell
injury.
To further examine the role of hydrogen peroxide in
FK506-induced cytotoxicity, we examined the effect of
FK506 in the presence of overexpressed catalase or Mn-
SOD in HEK 293 cells [13]. Because HEK293 cells do
not attach to plates well, release of LDH was used as an
index for cell viability. FK506 resulted in cell injury in
HEK293 cells in a lower dose than did in LLC-PK1 cells
(Fig. 5). Expression of catalase, but not MnSOD, ame-
liorated FK506-induced cell injury. In fact, expression
of MnSOD exacerbated FK506-induced release of LDH
(Fig. 5).
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Fig. 4. Neither 4,5-dihydroxy-1,2-benzene disulfonic acid (Tiron) nor
TEMPO inhibit FK506-mediated cytotoxicity and TEMPO potenti-
ates FK506-induced cell death associated with increased reactive oxy-
gen species (ROS) activity in LLC-PK1 cells. (A) Cells were incubated
with Tiron (3 mmol/L) or TEMPO (1 mmol/L) for 30 minutes prior
to addition of FK506. Cell viability was determined by the crystal vi-
olet assay 24 hours after treatments. (B) ROS activity was detected
by 2′ 7′-dichlorofluorescin diacetate (DCF-DA)-based flow cytometry
40 minutes after incubation with TEMPO. Each experiment was per-
formed in duplicate or triplicate. aP < 0.01, bP < 0.05 as compared with
respective control (N = 4 Student t test).
The protective effect of catalase is specific to FK506
To determine the specificity of the cytoprotective effect
of catalase, we examined the effect of catalase on TNF-
a-induced cell death in LLC-PK1 cells, because TNF-a–
induced injury has been implicated in the pathogenesis
of a variety of renal diseases [15]. LLC-PK1 cells are re-
sistant to TNF-a. However, inactivation of NF-jB by a
dominant negative mutant of IjBa sensitized the cells to
the cytokine. In contrast to the protective effect against
FK506-induced cell injury, catalase or sodium benzoate
had no significant effect on TNF-a–induced cell death.
On the contrary, TEMPO blunted TNF-a–induced cyto-
toxicity (Fig. 6).
DISCUSSION
A wide variety of drugs, cytokines, and toxins kill cells
through ROS [12, 13, 16]. However, few studies have
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Fig. 5. Overexpression of the human catalase, but not human man-
ganese superoxide dismutase (MnSOD) inhibits FK506-induced cell
death in human embryonic kidney (HEK293) cells. Symbols are: ()
Cells transfected with empty vector; () Cells expressing human cata-
lase; () Cells expressing human MnSOD. Cell viability was determined
by the lactate dehydrogenase (LDH) release assay 24 hours after treat-
ment. Each experiment was performed in duplicate or triplicate. aP <
0.01; bP < 0.05 as compared with respective control [N = 4, vehicle only,
analyses of variance (ANOVA)].
been conducted to examine the mechanism underlying
FK506-induced cell death, because it is assumed that
the actions of FK506 are similar to CsA, wherein ROS
mediate, at least in part, the cytotoxic effect. FK506 is
a macrolide antibiotic, whereas CsA is a cyclic unde-
capeptide. The present study provides direct evidence
showing that, although these two immunosuppressants
have different chemical structures, they share a common
toxic mechanism at least in cultured cells. More impor-
tantly, by overexpression of catalase and MnSOD, the
present study argues for the importance of hydrogen per-
oxide in the effect of FK506 and unique requirement of
catalase in cellular resistance to FK506-induced injury
in renal epithelial cells. Catalase completely attenuated
FK506-induced ROS activity and cell death (Figs. 2 to 5).
Moreover, superoxide anion scavengers, MnSOD, Tiron
or TEMPO, failed to show cytoprotection (Figs. 4 and
5). By undergoing alternate reduction and oxidation of
the chelated transition metals such as copper, iron, or
manganese, TEMPO acts like superoxide dismutase and
increases generation of hydrogen peroxide [17]. Consis-
tent with the present contention is that TEMPO and
expression of MnSOD exacerbated FK506-induced cell
death, and that TEMPO-induced cell death is associated
with increased ROS activity (Figs. 4 and 5). During the
course of this study, data have been reported suggesting
that hydrogen peroxide may also mediate CsA-induced
injury in LLC-PK1 cells [8]. Regarding a cellular mecha-
nism that is associated with the actions of hydrogen per-
oxide, Djavaheri-Mergny, Wietzerbin, and Besacon [18]
have demonstrated that hydrogen peroxide mediates 2-
methoxyestradiol-induced apoptosis in Ewing sarcoma
cells through activation of caspase-9 and c-Jun N-terminal
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Fig. 6. Neither catalase nor sodium benzoate protects LLC-PK1 cells
from tumor necrosis factor-a (TNF-a)-induced cell death. TEMPO
blunts the effect of TNF-a. (A) Cells stably expressing a dominant-
negative mutant of IjBa (Mutant) was identified by electrophoretic mo-
bility shift assays. (B) Symbols are: () Wild type cells; () Cells trans-
fected with empty vector; () Cells expressing the dominant-negative
mutant of IjBa. (C) Symbols are: (•) Mutant cells treated with 500 U/
mL catalase; () Mutant cells treated with 50 mmol/L sodium benzoate;
() Mutant cells treated with 1 mmol/L TEMPO. Cells were incubated
with catalase or TEMPO for 30 minutes, or sodium benzoate for 60 min-
utes prior to addition of TNF-a. Cell viability was determined by crystal
violet assays 24 hours after treatments. Each experiment was performed
in duplicate or triplicate. aP < 0.01 as compared with respective control
[N = 4, analyses of variance (ANOVA)].
kinase (JNK). Fujita et al [19] have reported that hydro-
gen peroxide activates poly(ADP-ribose) polymerase-
p53 pathway, which leads to up-regulation of Fas
and subsequent cell death in human airway epithelial
cells.
It is not clear how FK506 increases hydrogen per-
oxide generation. ROS are produced through a variety
of sources like mitochondrial oxidation, the microsomal
cytochrome P450 system, and plasma membrane nicoti-
namide adenine dinucleotide phosphate (NADPH) oxi-
dases. Ceramide induces generation of hydrogen perox-
ide at the ubiquinone site of the mitochondrial respira-
tory chain [20]. FK506 depresses renal catalase activity
[10]. FK506 decreases in vitro oxidative phosphorylation
of mitochondria [21]. More dimensions should be consid-
ered when identification of the source of ROS in vivo is
attempted. For example, CsA-induced hydroxyl radicals
are not derived directly from CsA, instead, from increas-
ing renal nerve activity [22]. However, it is worthwhile to
mention that the effect of FK506 on ROS activity is dose-
dependent. In nontoxic doses, FK506 exhibits antioxidant
effects [23].
Overexpression of catalase protects cells from injury
induced by mitomycin C [24] and glutathione deple-
tion [25], but not by cisplatin [13] or TNF-a [26]. The
present study has also shown that catalase does not offer
protection from TNF-a–induced cell death, thereby
demonstrating the unique specificity of catalase against
FK506-induced cell death (Fig. 6). Inhibition of TNF-a–
induced cell death by TEMPO is consistent with the view
regarding the requirement of superoxide dismutase in
resisting TNF-a–induced cytotoxicity [27]. Furthermore,
together with previous studies, the present report sug-
gests the importance of selective use of an anti-oxidant
such as catalase against oxidative stress. Although over-
expression of catalase inhibits cell injury induced by
FK506 (Fig. 5), mitomycin C [24] and glutathione
depletion [25], overexpression of catalase within the
cytosol or mitochondrial compartments exacerbates
TNF-a–mediated injury in HepG2 cells [28]. Likewise,
overexpression of MnSOD inhibits cisplatin cytotoxic-
ity [13], but enhances FK506-induced cell death (Fig. 5).
Therefore, a selective use of an antioxidant not only can
suppress oxidative injury effectively, but also avoid un-
desired consequences.
Although the concentration of FK506 that provokes
cell death is much higher than that found in vivo [29],
caution should be exercised when an attempt is made
to extrapolate results observed in vitro to in vivo, be-
cause these two conditions are quite different from each
other. For example, FK506 induces renal vasoconstric-
tion in vivo that creates ischemia, which may render cells
more sensitive to the drug [30]. Moreover, the metabo-
lite of FK506 that is produced by hepatic cytochrome
P450 is seven times more toxic that the parent drug
[31]. Nevertheless, consistent with the present notion of
a critical role of hydrogen peroxide in FK506 cytotoxi-
city is that FK506 causes lipid peroxidation in rat liver
preparations that was inhibited by catalase more than by
MnSOD [32]. Furthermore, CsA decreases catalase and
glutathione peroxidase activities, but has no signifi-
cant effect on superoxide dismutase activity in rabbit
kidney tissues [9]. Although superoxide dismutase at-
tenuates rat kidney from ischemia/reperfusion-induced
injury, the enzyme does not ameliorate CsA nephrotoxi-
city [33]. Subcutaneous injection of superoxide dismutase
was reported to ameliorate CsA-triggered renal damage
in rats [34]. However, in view of the fact that superox-
ide dismutase is not readily membrane-permeable, an ef-
fect other than ROS scavenging cannot be ruled out. Of
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note, nephrotoxicity induced by FK506 is primarily due
to vascular injury, rather than a direct proximal tubular
cell damage [2–4]. While the present results shed light on
how FK506 induces cell injury in tubules, the relevance
to the endothelium and possible in vivo ischemic injury
remains a matter for speculation.
The degree of reduced cell viability estimated by LDH
release assays was smaller than that measured by crys-
tal violet assays. The reason for this difference may be
due to apoptotic form of cell injury. When epithelial cells
undergo apoptosis and necrosis, they detach from plates.
Crystal violet stains cells remaining attached to plates.
During the early stage of apoptosis, the cell membrane
remains intact and the amount of LDH released into the
medium is small or negligible. It is possible that a signifi-
cant portion of FK506-induced cell death is through apop-
tosis as demonstrated in brain capillary endothelial cells
[35]. In substantiation of this notion, FK506 markedly
increased caspase-3 like activity and hypodiploid nuclei
(Fig. 1C to F).
CONCLUSION
The results of this study demonstrate an important role
for hydrogen peroxide in FK506-induced toxicity in renal
cells. Strategies to block the production of ROS, specif-
ically hydrogen peroxide, by overexpressing catalase or
scavengers of hydrogen peroxide, would provide poten-
tial therapeutic avenues in FK506-mediated nephrotoxi-
city and merit further investigation.
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